TipRanks
Biocryst Pharmaceuticals (DE:BO1)
FRANKFURT:BO1
Germany Market
BO1
BioCryst
RESEARCH TOOLSreports

BioCryst (BO1) Balance Sheet

2 Followers

BioCryst Balance Sheet

BioCryst's total assets for Q2 2026 were $557.85M, an increase of 19.95% from the previous quarter. DE:BO1 total liabilities were $1.01B for the fiscal quarter, a -0.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 514.16M$ 490.42M$ 516.96M$ 550.00M$ 588.15M
Total Liabilities
$ 633.31M$ 966.35M$ 972.49M$ 844.60M$ 695.14M
Total Equity Gross Minority
$ -119.15M$ -475.93M$ -455.53M$ -294.60M$ -106.99M
Other Metrics
Currency in USD

BioCryst Debt to Assets